Verition Fund Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,698
Closed -$156K 2928
2023
Q4
$156K Sell
20,698
-50,000
-71% -$411K ﹤0.01% 2090
2023
Q3
$725K Buy
70,698
+4,400
+7% +$54.3K 0.01% 1242
2023
Q2
$914K Buy
66,298
+39,440
+147% +$592K 0.01% 965
2023
Q1
$436K Sell
26,858
-92,900
-78% -$1.75M 0.01% 1318
2022
Q4
$2.12M Buy
119,758
+45,736
+62% +$908K 0.03% 600
2022
Q3
$1.45M Buy
+74,022
New +$1.57M 0.02% 1129

Other funds holding PETS

Verition Fund Management's PETS Position: Q1 2024 in Review

Verition Fund Management sold out of PetMed Express (PETS) in Q1 2024, closing a stake of 20,698 shares — an estimated $156K sold.

Verition Fund Management first reported a position in PETS in Q3 2022 and held it in 6 quarters. The position peaked at $2.12M in Q4 2022. 116 funds tracked by Wall St. Rank hold PETS as of Q1 2024.

  • Verition Fund Management reported no remaining PetMed Express position as of Q1 2024 after selling out during the quarter.
  • Verition Fund Management sold 20,698 PetMed Express shares in Q1 2024, an estimated $156K.
  • Verition Fund Management first reported a position in PetMed Express in Q3 2022 and held it in 6 quarters.
  • Verition Fund Management's PetMed Express position peaked at $2.12M in Q4 2022.
  • 116 funds tracked by Wall St. Rank held PetMed Express as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.